Chester County News and Community Website
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) this week announced that it has received a written pre-investigational new drug (pre-IND) response from the U.S. Food and Drug Administration (FDA) …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced on Friday that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application …
Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that its resubmitted New Drug Application (NDA) for …
Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, announced that the U.S. Food and Drug Administration …
Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced that, on June 24, 2020, the …
Read More
SILVER SPRING, MD — The U.S. Food and Drug Administration is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance …
Read More